Related Stories

16 de January de 2023
On Epiphany, the U.S. Food and Drug Administration approved a new drug for early-stage Alzheimer’s…


12 de December de 2019

20 de September de 2019
Our team participated in a phase II clinical trial, with an antiamyloid monoclonal antibody in…
Posted in: Alzeimer


14 de March de 2019
Our Unit participated in a Phase II clinical trial, with a monoclonal anti-amyloid in Alzheimer’s,…
Posted in: Alzeimer, Uncategorised

1 de March de 2019
Our Unit has surpassed two centers from the United States in the randomization of patients…
Posted in: Alzeimer, Uncategorised